• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与氟喹诺酮类化学结构相关的药代动力学相互作用。

Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.

作者信息

Mizuki Y, Fujiwara I, Yamaguchi T

机构信息

Department of Pharmacokinetics, Dainippon Pharmaceutical Co., Ltd, Osaka, Japan.

出版信息

J Antimicrob Chemother. 1996 May;37 Suppl A:41-55. doi: 10.1093/jac/37.suppl_a.41.

DOI:10.1093/jac/37.suppl_a.41
PMID:8737124
Abstract

Fluoroquinolone derivatives interact with methylxanthines (theophylline, caffeine) and metallic ion-containing drugs to different degrees. The rat appears to be a suitable model for predicting such interactions in man. It has been possible to determine the relationship between the chemical structure of the fluoroquinolone and the magnitude of the interaction. Fluoroquinolones with a bulky substituent at the position 8, such as sparfloxacin, lomefloxacin and fieroxacin, are less prone to interact with theophylline than those without an 8-substituent, such as enoxacin. This substituent determines the planarity of the whole fluoroquinolone molecule and the interaction tends to be more significant for planar fluoroquinolones. Furthermore, a 4'-nitrogen atom in the 7-piperazinyl group is essential for the interaction to occur. The nitrogen atom is possibly the site that binds cytochrome P-450, which catalyses theophylline metabolism. The reduction in bioavailability of fluoroquinolones by concurrent administration of aluminium hydroxide is more striking for derivatives with fewer substituents on the essential structure and on the piperazinyl group, such as norfloxacin, ciprofloxacin and enoxacin. Substitution at the 5-position diminishes the interaction, which suggests that the 5-substituent may affect the formation and/or stability of unabsorbable chelate complex which is the probable cause of the interaction. These findings are potentially useful in designing fluoroquinolones less prone to drug interactions.

摘要

氟喹诺酮衍生物与甲基黄嘌呤(茶碱、咖啡因)以及含金属离子的药物存在不同程度的相互作用。大鼠似乎是预测人体此类相互作用的合适模型。已能够确定氟喹诺酮的化学结构与相互作用强度之间的关系。在8位带有庞大取代基的氟喹诺酮,如司帕沙星、洛美沙星和氟罗沙星,与茶碱相互作用的可能性低于那些没有8位取代基的氟喹诺酮,如依诺沙星。该取代基决定了整个氟喹诺酮分子的平面性,对于平面型氟喹诺酮,相互作用往往更为显著。此外,7 - 哌嗪基中的4'-氮原子对于相互作用的发生至关重要。该氮原子可能是与催化茶碱代谢的细胞色素P - 450结合的位点。同时给予氢氧化铝时,对于在基本结构和哌嗪基上取代基较少的衍生物,如诺氟沙星、环丙沙星和依诺沙星,氟喹诺酮生物利用度的降低更为显著。在5位进行取代可减少相互作用,这表明5位取代基可能会影响不可吸收螯合物的形成和/或稳定性,而这种螯合物可能是相互作用的原因。这些发现对于设计不易发生药物相互作用的氟喹诺酮可能具有潜在用途。

相似文献

1
Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.与氟喹诺酮类化学结构相关的药代动力学相互作用。
J Antimicrob Chemother. 1996 May;37 Suppl A:41-55. doi: 10.1093/jac/37.suppl_a.41.
2
Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomes.抗菌药物依诺沙星及其衍生物对大鼠肝微粒体茶碱代谢的结构相关抑制作用。
Antimicrob Agents Chemother. 1996 Aug;40(8):1875-80. doi: 10.1128/AAC.40.8.1875.
3
Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.氟喹诺酮类药物与其他药物的相互作用:作用机制、变异性、临床意义及处理
Clin Infect Dis. 1992 Jan;14(1):272-84. doi: 10.1093/clinids/14.1.272.
4
Drug-drug interactions with fluoroquinolones.氟喹诺酮类药物的药物相互作用。
Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):23S-28S.
5
The effects of quinolones on xanthine pharmacokinetics.喹诺酮类药物对黄嘌呤药代动力学的影响。
Am J Med. 1992 Apr 6;92(4A):22S-25S. doi: 10.1016/0002-9343(92)90303-s.
6
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.氟喹诺酮类药物与合成左旋多巴黑色素的结合特性
J Pharm Pharmacol. 2003 Aug;55(8):1127-33. doi: 10.1211/002235703322277168.
7
Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
Am J Med. 1992 Apr 6;92(4A):18S-21S. doi: 10.1016/0002-9343(92)90302-r.
8
Clinical pharmacokinetics of sparfloxacin.司帕沙星的临床药代动力学
Clin Pharmacokinet. 1993 Nov;25(5):358-69. doi: 10.2165/00003088-199325050-00002.
9
Drug-drug interactions with ciprofloxacin and other fluoroquinolones.环丙沙星及其他氟喹诺酮类药物的药物相互作用。
Am J Med. 1989 Nov 30;87(5A):76S-81S. doi: 10.1016/0002-9343(89)90028-4.
10
Drug interactions with quinolones.喹诺酮类药物的药物相互作用。
J Antimicrob Chemother. 1990 Nov;26 Suppl D:7-29. doi: 10.1093/jac/26.suppl_d.7.

引用本文的文献

1
Safety analysis of quinolones use in minors-based on the FAERS database.基于美国食品药品监督管理局不良事件报告系统(FAERS)数据库的喹诺酮类药物在未成年人中使用的安全性分析。
Front Med (Lausanne). 2024 Aug 29;11:1437376. doi: 10.3389/fmed.2024.1437376. eCollection 2024.
2
studies of the quantitative effect of calcium, multivitamins and milk on single dose ciprofloxacin bioavailability.钙、多种维生素和牛奶对单剂量环丙沙星生物利用度的定量影响研究。
J Pharm Anal. 2015 Dec;5(6):389-395. doi: 10.1016/j.jpha.2015.02.003. Epub 2015 Mar 10.
3
Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
接受口服氟喹诺酮类药物治疗的患者发生胃肠道穿孔的风险:一项基于全国代表性队列的分析。
PLoS One. 2017 Sep 5;12(9):e0183813. doi: 10.1371/journal.pone.0183813. eCollection 2017.
4
Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers.含铝(3+)和镁(2+)的抗酸剂、硫酸亚铁及碳酸钙对健康中国志愿者中奈诺沙星(TG - 873870)吸收的影响。
Acta Pharmacol Sin. 2014 Dec;35(12):1586-92. doi: 10.1038/aps.2014.95. Epub 2014 Oct 20.
5
Interactions between new quinolone antibacterials and diagnostic drug containing manganese.新型喹诺酮类抗菌药物与含锰诊断药物之间的相互作用。
Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):255-9. doi: 10.1007/s13318-013-0120-6. Epub 2013 Feb 27.
6
Diaqua-(5-carb-oxy-benzene-1,3-dicarboxyl-ato-κO(1))[8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato-κ(2)O(5),O(6)]zinc monohydrate.一水合二水合-(5-羧基苯-1,3-二羧酸根合-κO(1))[8-乙基-5-氧代-2-(哌嗪-4-鎓-1-基)-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸根合-κ(2)O(5),O(6)]锌
Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):m127. doi: 10.1107/S1600536813002122. Epub 2013 Jan 31.
7
Sparfloxacin: An Overview of Its Efficacy in ENT Infections.司帕沙星:其在耳鼻喉感染中疗效的概述
Indian J Otolaryngol Head Neck Surg. 1997 Oct;49(4):415-21. doi: 10.1007/BF02994667.
8
The new fluoroquinolones: A critical review.新型氟喹诺酮类药物:批判性综述。
Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394.
9
Clinically significant drug interactions with antacids: an update.与抗酸剂有临床意义的药物相互作用:更新。
Drugs. 2011 Oct 1;71(14):1839-64. doi: 10.2165/11593990-000000000-00000.
10
Bis[8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carb-oxy-lic acid] 2,5-dicarb-oxy-benzene-1,4-di-carboxyl-ate octa-hydrate.双[8-乙基-5-氧代-2-(哌嗪-4-鎓-1-基)-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸] 2,5-二羧酸苯-1,4-二羧酸酯八水合物
Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 1;67(Pt 4):o1011-2. doi: 10.1107/S1600536811011068. Epub 2011 Mar 31.